| Presenter: Judith Tsui, MD, MPH, Associate Professor, University of Washington Sponsors: American Psychiatric Association (APA) and American Academy of Addiction Psychiatry (AAAP) Cost: No Fee Target audience: This activity is designed for interprofessional teams, nurses, pharmacists, physician assistants, physicians, psychiatrists, and social workers. This activity is accredited for interprofessional teams, nurses, pharmacists, physician assistants, physicians, and social workers. Credit Designations Available: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit, SW CE credit, Pharmacy CE credit, IPCE credit About the webinar: The Hepatitis C Virus is an RNA virus that is not vaccine preventable and is the most common blood-borne infection in the U.S. The majority of people exposed to the virus will develop chronic infection, and it has evolved into an intergenerational epidemic; baby boomers and young people who inject drugs are the most afflicted. This webinar aims to show providers the treatment techniques when working with a patient with co-morbid SUD and HCV. Educational objectives: At the conclusion of this activity participants should be able to: - Explain hepatitis C elimination campaigns and that prior authorization requirements and provider restrictions have been lifted.
- Compare and contrast treatment techniques which are specific to people who use drugs (PWUD).
- Use adult HCV screening methods and evaluate treatment methods if a patient has the infection.
- Work with healthcare team to identify methods to use direct-acting antivirals (DAAs) and to implement key steps in treatment.
| 